Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Thalidomide

EU orphan designation number: EU/3/01/067   
Active ingredient: Thalidomide
Indication: Treatment of multiple myeloma
Sponsor: Celgene Europe Limited
1 Longwalk Road, Stockley Park, Uxbridge, Middlesex UB11 1DB, United Kingdom
EU Centralised marketing authorisation: A centralised EU marketing authorisation has been obtained under the name Thalidomide Celgene on 16/04/2008 with the number EU/1/08/443

   Public summary of scientific opinion     EPAR

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
21/11/2001 Centralised Orphan - Designation EMEA/OD/040/01 (2001)3567 of 20/11/2001
25/07/2005 Other procedure
02/12/2008 Centralised Orphan - Transfer of orphan designation EMEA/OD/040/01/T/01 (2008)7793 of 28/11/2008
30/05/2011 Other procedure EMEA/OD/019/01